Metastatic Cancer Cells Are More Sensitive to TRAIL
Author Information
Author(s): Kim Hak-Bong, Kim Mi-Ju, Kim Dae-Young, Lee Jae-Won, Bae Jae-Ho, Kim Dong-Wan, Kang Chi-Dug, Kim Sun-Hee
Primary Institution: Pusan National University School of Medicine
Hypothesis
The study investigates the differential TRAIL responsiveness of metastatic cancer cells compared to their primary counterparts.
Conclusion
The study indicates that TRAIL may be an effective treatment for metastatic cancers that overexpress c-Myc.
Supporting Evidence
- Metastatic cells showed higher levels of c-Myc and DNA-PKcs, making them more susceptible to TRAIL.
- TRAIL treatment led to increased activation of caspases in metastatic cells compared to primary cells.
- 4,5-dimethoxy-2-nitrobenzaldehyde enhanced TRAIL-induced apoptosis in TRAIL-insensitive cells.
Takeaway
Some cancer cells that spread to other parts of the body are easier to kill with a special treatment called TRAIL, especially if they have a certain protein called c-Myc.
Methodology
The study involved treating human prostate and colon cancer cells with TRAIL and measuring their apoptosis and caspase activation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website